| Literature DB >> 19560924 |
Luke R Odell1, Mikael T Nilsson, Johan Gising, Olof Lagerlund, Daniel Muthas, Anneli Nordqvist, Anders Karlén, Mats Larhed.
Abstract
3-Amino-imidazo[1,2-a]pyridines have been identified as a novel class of Mycobacterium tuberculosis glutamine synthetase inhibitors. Moreover, these compounds represent the first drug-like inhibitors of this enzyme. A series of compounds exploring structural diversity in the pyridine and phenyl rings have been synthesized and biologically evaluated. Compound 4n was found to be the most potent inhibitor (IC(50)=0.38+/-0.02 microM). This compound was significantly more potent than the known inhibitors, l-methionine-SR-sulfoximine and phosphinothricin.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19560924 DOI: 10.1016/j.bmcl.2009.06.045
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823